MET and gastric cancer: MET gene amplification has been reported to exhibit constitutive ligand‐independent MET activation through receptor dimerization,57, 58 which acts as a primary “oncogenic driver” that might indicate poor prognosis in patients with gastric cancer.28, 30, 31, 59, 60